D Moneghini Selected Research

CR 2945

1/2002	Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: follow-up at 52 weeks.
3/2001	Distribution of 1,2 DMH-induced colonic aberrant crypt foci after administration of a gastrin receptor antagonist (CR2945), in the murine model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Moneghini Research Topics

Disease

2	Colonic Neoplasms (Colon Cancer) 01/2002 - 03/2001
2	Carcinogenesis 01/2002 - 03/2001
1	Morbid Obesity 07/2004
1	Obesity 07/2004
1	Carcinoma (Carcinomatosis) 02/2003
1	Neoplasms (Cancer) 01/2002
1	Adenocarcinoma 01/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2002
1	Intestinal Diseases (Diseases, Intestinal) 11/2001
1	Aberrant Crypt Foci 03/2001

Drug/Important Bio-Agent (IBA)

2	Cholecystokinin B ReceptorIBA 01/2002 - 03/2001
2	Dimenhydrinate (DMH)FDA LinkGeneric 01/2002 - 03/2001
2	DimethylhydrazinesIBA 01/2002 - 03/2001
2	CR 2945IBA 01/2002 - 03/2001
1	vasectrin II (VS II)IBA 02/2003
1	vasectrin IIIIBA 02/2003
1	MucinsIBA 02/2003
1	GastrinsIBA 01/2002
1	Cholecystokinin (Pancreozymin)IBA 01/2002

Therapy/Procedure

1	Bariatric Surgery 07/2004
1	Biliopancreatic Diversion 07/2004
1	Colectomy 11/2001